Investigator-Initiated Trials Recruitment: A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD

Dr. Anne Wagner and a team of researchers at Remedy Institute in Toronto, Canada are conducting a treatment development study of MDMA-assisted cognitive processing therapy (CPT) for individuals with posttraumatic stress disorder (PTSD). This investigator-initiated trial is currently recruiting and will treat up to 10 participants. Visit the official study page on to learn more.